90 results on '"Freedman, D. M."'
Search Results
2. Incidence of Haematopoietic Malignancies in US Radiologic Technologists
- Author
-
Linet, M. S., Freedman, D. M., Mohan, A. K., Doody, M. M., Ron, E., Mabuchi, K., Alexander, B. H., Sigurdson, A., and Hauptmann, M.
- Published
- 2005
- Full Text
- View/download PDF
3. Sunlight and Mortality from Breast, Ovarian, Colon, Prostate, and Non-Melanoma Skin Cancer: A Composite Death Certificate Based Case-Control Study
- Author
-
Freedman, D. M., Dosemeci, M., and McGlynn, K.
- Published
- 2002
4. Bladder cancer and drinking water: a population-based case-control study in Washington County, Maryland (United States)
- Author
-
Freedman, D. M., Cantor, K. P., Lee, N. L., Chen, L.-S., Lei, H.-H., Ruhl, C. E., and Wang, S. S.
- Published
- 1997
- Full Text
- View/download PDF
5. Body mass index and all-cause mortality in a nationwide US cohort
- Author
-
Freedman, D M, Ron, E, Ballard-Barbash, R, Doody, M M, and Linet, M S
- Published
- 2006
6. Coffee, tea, and caffeine intake and amyotrophic lateral sclerosis mortality in a pooled analysis of eight prospective cohort studies.
- Author
-
Petimar, J, O'Reilly, É, Adami, H-O, van den Brandt, P A, Buring, J, English, D R, Freedman, D M, Giles, G G, Håkansson, N, Kurth, T, Larsson, Susanna C., Robien, K, Schouten, L J, Weiderpass, E, Wolk, Alicja, Smith-Warner, S A, Petimar, J, O'Reilly, É, Adami, H-O, van den Brandt, P A, Buring, J, English, D R, Freedman, D M, Giles, G G, Håkansson, N, Kurth, T, Larsson, Susanna C., Robien, K, Schouten, L J, Weiderpass, E, Wolk, Alicja, and Smith-Warner, S A
- Abstract
BACKGROUND AND PURPOSE: Caffeine is associated with a lower risk of some neurological diseases, but few prospective studies have investigated caffeine intake and risk of amyotrophic lateral sclerosis (ALS) mortality. We therefore determined associations between coffee, tea and caffeine intake, and risk of ALS mortality. METHODS: We conducted pooled analyses of eight international, prospective cohort studies, including 351 565 individuals (120 688 men and 230 877 women). We assessed coffee, tea and caffeine intake using validated food-frequency questionnaires administered at baseline. We used Cox regression to estimate study- and sex-specific risk ratios and 95% confidence intervals (CI) for ALS mortality, which were then pooled using a random-effects model. We conducted analyses using cohort-specific tertiles, absolute common cut-points and continuous measures of all exposures. RESULTS: During follow-up, 545 ALS deaths were documented. We did not observe statistically significant associations between coffee, tea or caffeine intake and risk of ALS mortality. The pooled multivariable risk ratio (MVRR) for ≥3 cups per day vs. >0 to <1 cup per day was 1.04 (95% CI, 0.74-1.47) for coffee and 1.17 (95% CI, 0.77-1.79) for tea. The pooled MVRR comparing the highest with the lowest tertile of caffeine intake (mg/day) was 0.99 (95% CI, 0.80-1.23). No statistically significant results were observed when exposures were modeled as tertiles or continuously. CONCLUSIONS: Our results do not support associations between coffee, tea or total caffeine intake and risk of ALS mortality.
- Published
- 2019
- Full Text
- View/download PDF
7. Coffee, tea, and caffeine intake and amyotrophic lateral sclerosis mortality in a pooled analysis of eight prospective cohort studies
- Author
-
Petimar, J., Petimar, J., O'Reilly, E., Adami, H. -O., van den Brandt, P. A., Buring, J., English, D. R., Freedman, D. M., Giles, G. G., Hakansson, N., Kurth, T., Larsson, S. C., Robien, K., Schouten, L. J., Weiderpass, E., Wolk, A., Smith-Warner, S. A., Petimar, J., Petimar, J., O'Reilly, E., Adami, H. -O., van den Brandt, P. A., Buring, J., English, D. R., Freedman, D. M., Giles, G. G., Hakansson, N., Kurth, T., Larsson, S. C., Robien, K., Schouten, L. J., Weiderpass, E., Wolk, A., and Smith-Warner, S. A.
- Abstract
Background and purposeCaffeine is associated with a lower risk of some neurological diseases, but few prospective studies have investigated caffeine intake and risk of amyotrophic lateral sclerosis (ALS) mortality. We therefore determined associations between coffee, tea and caffeine intake, and risk of ALS mortality.MethodsWe conducted pooled analyses of eight international, prospective cohort studies, including 351565 individuals (120688 men and 230877 women). We assessed coffee, tea and caffeine intake using validated food-frequency questionnaires administered at baseline. We used Cox regression to estimate study- and sex-specific risk ratios and 95% confidence intervals (CI) for ALS mortality, which were then pooled using a random-effects model. We conducted analyses using cohort-specific tertiles, absolute common cut-points and continuous measures of all exposures.ResultsDuring follow-up, 545 ALS deaths were documented. We did not observe statistically significant associations between coffee, tea or caffeine intake and risk of ALS mortality. The pooled multivariable risk ratio (MVRR) for 3 cups per day vs. >0 toConclusionsOur results do not support associations between coffee, tea or total caffeine intake and risk of ALS mortality.
- Published
- 2019
8. Coffee, tea, and caffeine intake and amyotrophic lateral sclerosis mortality in a pooled analysis of eight prospective cohort studies
- Author
-
Petimar, J., primary, O'Reilly, É., additional, Adami, H.‐O., additional, Brandt, P. A., additional, Buring, J., additional, English, D. R., additional, Freedman, D. M., additional, Giles, G. G., additional, Håkansson, N., additional, Kurth, T., additional, Larsson, S. C., additional, Robien, K., additional, Schouten, L. J., additional, Weiderpass, E., additional, Wolk, A., additional, and Smith‐Warner, S. A., additional
- Published
- 2018
- Full Text
- View/download PDF
9. Menopausal hormone use and ovarian cancer risk : Individual participant meta-analysis of 52 epidemiological studies
- Author
-
Gapstur, S. M., Patel, A. V., Banks, E., Dal Maso, L., Talamini, R., Chetrit, A., Hirsh-Yechezkel, G., Lubin, F., Sadetzki, S., Beral, V., Bull, D., Cairns, B., Crossley, B., Gaitskell, K., Goodill, A., Green, J., Hermon, C., Key, T., Moser, K., Reeves, G., Sitas, F., Collins, R., Peto, R., Gonzalez, C. A., Lee, N., Marchbanks, P., Ory, H. W., Peterson, H. B., Wingo, P. A., Martin, N., Silpisornkosol, S., Theetranont, C., Boosiri, B., Chutivongse, S., Jimakorn, P., Virutamasen, P., Wongsrichanalai, C., Goodman, M. T., Lidegaard, O., Kjaer, S. K., Morch, L. S., Tjonneland, A., Byers, T., Rohan, T., Mosgaard, B., Vessey, M., Yeates, D., Freudenheim, J. L., Titus, L. J., Chang-Claude, J., Kaaks, R., Anderson, K. E., Lazovich, D., Robien, K., Hampton, J., Newcomb, P. A., Rossing, M. A., Thomas, D. B., Weiss, N. S., Lokkegaard, E., Riboli, E., Clavel-Chapelon, F., Cramer, D., Hankinson, S. E., Tamimi, R. M., Tworoger, S. S., Franceschi, S., La Vecchia, C., Negri, E., Adami, H. O., Magnusson, C., Riman, T., Weiderpass, E., Wolk, A., Schouten, L. J., van den Brandt, P. A., Chantarakul, N., Koetsawang, S., Rachawat, D., Palli, D., Black, A., Brinton, L. A., Freedman, D. M., Hartge, P., Hsing, A. W., Jnr, J. V. Lacey, Lissowska, J., Hoover, R. N., Schairer, C., Babb, C., Urban, M., Graff-Iversen, S., Selmer, R., Bain, C. J., Green, A. C., Purdie, D. M., Siskind, V., Webb, P. M., Moysich, K., McCann, S. E., Hannaford, P., Kay, C., Binns, C. W., Lee, A. H., Zhang, M., Ness, R. B., Nasca, P., Coogan, P. F., Palmer, J. R., Rosenberg, L., Whittemore, A., Katsouyanni, K., Trichopoulou, A., Trichopoulos, D., Tzonou, A., Dabancens, A., Martinez, L., Molina, R., Salas, O., Lurie, G., Carney, M. E., Wilkens, L. R., Werner Hartman, Linda, Manjer, Jonas, Olsson, Håkan, Kumle, M., Grisso, J. A., Morgan, M., Wheeler, J. E., Edwards, R. P., Kelley, J. L., Modugno, F., Onland-Moret, N. C., Peeters, P. H. M., Casagrande, J., Pike, M. C., Wu, A. H., Canfell, K., Miller, A. B., Gram, I. T., Lund, E., McGowan, L., Shu, X. O., Zheng, W., Farley, T. M. M., Holck, S., Meirik, O., Risch, H. A., S. M. Gapstur, A. V. Patel, E. Bank, L. Dal Maso, R. Talamini, A. Chetrit, G. Hirsh Yechezkel, F. Lubin, S. Sadetzki, V. Beral, D. Bull, B. Cairn, B. Crossley, K. Gaitskell, A. Goodill, J. Green, C. Hermon, T. Key, K. Moser, G. Reeve, F. Sita, R. Collin, R. Peto, C. A. Gonzalez, N. Lee, P. Marchbank, H. W. Ory, H. B. Peterson, P. A. Wingo, N. Martin, S. Silpisornkosol, C. Theetranont, B. Boosiri, S. Chutivongse, P. Jimakorn, P. Virutamasen, C. Wongsrichanalai, M. T. Goodman, O. Lidegaard, S. K. Kjaer, L. S. Morch, A. Tjonneland, T. Byer, T. Rohan, B. Mosgaard, M. Vessey, D. Yeate, J. L. Freudenheim, L. J. Titu, J. Chang Claude, R. Kaak, K. E. Anderson, D. Lazovich, K. Robien, J. Hampton, P. A. Newcomb, M. A. Rossing, D. B. Thoma, N. S. Wei, E. Lokkegaard, E. Riboli, F. Clavel Chapelon, D. Cramer, S. E. Hankinson, R. M. Tamimi, S. S. Tworoger, S. Franceschi, C. La Vecchia, E. Negri, H. O. Adami, C. Magnusson, T. Riman, E. Weiderpa, A. Wolk, L. J. Schouten, P. A. van den Brandt, N. Chantarakul, S. Koetsawang, D. Rachawat, D. Palli, A. Black, L. A. Brinton, D. M. Freedman, P. Hartge, A. W. Hsing, J. V. L. Jnr, J. Lissowska, R. N. Hoover, C. Schairer, C. Babb, M. Urban, S. Graff Iversen, R. Selmer, C. J. Bain, A. C. Green, D. M. Purdie, V. Siskind, P. M. Webb, K. Moysich, S. E. McCann, P. Hannaford, C. Kay, C. W. Binn, A. H. Lee, M. Zhang, R. B. Ne, P. Nasca, P. F. Coogan, J. R. Palmer, L. Rosenberg, A. Whittemore, K. Katsouyanni, A. Trichopoulou, D. Trichopoulo, A. Tzonou, A. Dabancen, L. Martinez, R. Molina, O. Sala, G. Lurie, M. E. Carney, L. R. Wilken, L. Hartman, J. Manjer, H. Olsson, M. Kumle, J. A. Grisso, M. Morgan, J. E. Wheeler, R. P. Edward, J. L. Kelley, F. Modugno, N. C. Onland Moret, P. H. M. Peeter, J. Casagrande, M. C. Pike, A. H. Wu, K. Canfell, A. B. Miller, I. T. Gram, E. Lund, L. McGowan, X. O. Shu, W. Zheng, T. M. M. Farley, S. Holck, O. Meirik, H. A. Risch, Epidemiologie, RS: CAPHRI School for Public Health and Primary Care, RS: CAPHRI - R3 - Functioning, Participating and Rehabilitation, RS: CAPHRI - R5 - Optimising Patient Care, RS: GROW - Oncology, and RS: GROW - R1 - Prevention
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Etiology - Endogenous Factors in the Origin and Cause of Cancer ,ovarian neoplasm ,THERAPY ,Medicine, General & Internal ,Internal medicine ,General & Internal Medicine ,Epidemiology ,middle aged ,medicine ,Cancer Type - Ovarian Cancer ,estrogen replacement therapy ,human ,Prospective cohort study ,medicine (all) ,Gynecology ,Science & Technology ,business.industry ,drug administration schedule ,WOMEN ,risk assessment ,Retrospective cohort study ,General Medicine ,11 Medical And Health Sciences ,medicine.disease ,postmenopause ,female ,Meta-analysis ,Relative risk ,Cancer and Oncology ,incidence ,Hormone therapy ,HEALTH ,Risk assessment ,Ovarian cancer ,business ,Life Sciences & Biomedicine - Abstract
SummaryBackgroundHalf the epidemiological studies with information about menopausal hormone therapy and ovarian cancer risk remain unpublished, and some retrospective studies could have been biased by selective participation or recall. We aimed to assess with minimal bias the effects of hormone therapy on ovarian cancer risk.MethodsIndividual participant datasets from 52 epidemiological studies were analysed centrally. The principal analyses involved the prospective studies (with last hormone therapy use extrapolated forwards for up to 4 years). Sensitivity analyses included the retrospective studies. Adjusted Poisson regressions yielded relative risks (RRs) versus never-use.FindingsDuring prospective follow-up, 12 110 postmenopausal women, 55% (6601) of whom had used hormone therapy, developed ovarian cancer. Among women last recorded as current users, risk was increased even with
- Published
- 2015
10. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies
- Author
-
Gapstur, S. M. Patel, A. V. Banks, E. Dal Maso, L. and Talamini, R. Chetrit, A. Hirsh-Yechezkel, G. Lubin, F. and Sadetzki, S. Beral, V. Bull, D. Cairns, B. Crossley, B. and Gaitskell, K. Goodill, A. Green, J. Hermon, C. Key, T. Moser, K. Reeves, G. Sitas, F. Collins, R. Peto, R. Gonzalez, C. A. Lee, N. Marchbanks, P. Ory, H. W. and Peterson, H. B. Wingo, P. A. Martin, N. Silpisornkosol, S. and Theetranont, C. Boosiri, B. Chutivongse, S. Jimakorn, P. and Virutamasen, P. Wongsrichanalai, C. Goodman, M. T. and Lidegaard, O. Kjaer, S. K. Morch, L. S. Tjonneland, A. and Byers, T. Rohan, T. Mosgaard, B. Vessey, M. Yeates, D. and Freudenheim, J. L. Titus, L. J. Chang-Claude, J. Kaaks, R. Anderson, K. E. Lazovich, D. Robien, K. Hampton, J. and Newcomb, P. A. Rossing, M. A. Thomas, D. B. Weiss, N. S. and Lokkegaard, E. Riboli, E. Clavel-Chapelon, F. Cramer, D. and Hankinson, S. E. Tamimi, R. M. Tworoger, S. S. and Franceschi, S. La Vecchia, C. Negri, E. Adami, H. O. and Magnusson, C. Riman, T. Weiderpass, E. Wolk, A. and Schouten, L. J. van den Brandt, P. A. Chantarakul, N. and Koetsawang, S. Rachawat, D. Palli, D. Black, A. Brinton, L. A. Freedman, D. M. Hartge, P. Hsing, A. W. Jnr, J. V. Lacey Lissowska, J. Hoover, R. N. Schairer, C. Babb, C. and Urban, M. Graff-Iversen, S. Selmer, R. Bain, C. J. and Green, A. C. Purdie, D. M. Siskind, V. Webb, P. M. and Moysich, K. McCann, S. E. Hannaford, P. Kay, C. Binns, C. W. Lee, A. H. Zhang, M. Ness, R. B. Nasca, P. and Coogan, P. F. Palmer, J. R. Rosenberg, L. Whittemore, A. and Katsouyanni, K. Trichopoulou, A. Trichopoulos, D. Tzonou, A. and Dabancens, A. Martinez, L. Molina, R. Salas, O. and Lurie, G. Carney, M. E. Wilkens, L. R. Hartman, L. and Manjer, J. Olsson, H. Kumle, M. Grisso, J. A. Morgan, M. and Wheeler, J. E. Edwards, R. P. Kelley, J. L. Modugno, F. and Onland-Moret, N. C. Peeters, P. H. M. Casagrande, J. and Pike, M. C. Wu, A. H. Canfell, K. Miller, A. B. Gram, I. T. Lund, E. McGowan, L. Shu, X. O. Zheng, W. Farley, T. M. M. Holck, S. Meirik, O. Risch, H. A. Collaborative Grp Epidemiological
- Abstract
Background Half the epidemiological studies with information about menopausal hormone therapy and ovarian cancer risk remain unpublished, and some retrospective studies could have been biased by selective participation or recall. We aimed to assess with minimal bias the effects of hormone therapy on ovarian cancer risk. Methods Individual participant datasets from 52 epidemiological studies were analysed centrally. The principal analyses involved the prospective studies (with last hormone therapy use extrapolated forwards for up to 4 years). Sensitivity analyses included the retrospective studies. Adjusted Poisson regressions yielded relative risks (RRs) versus never-use. Findings During prospective follow-up, 12 110 postmenopausal women, 55% (6601) of whom had used hormone therapy, developed ovarian cancer. Among women last recorded as current users, risk was increased even with
- Published
- 2015
11. Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies
- Author
-
Beral, V. Gaitskell, K. Hermon, C. Moser, K. Reeves, G. and Peto, R. Brinton, L. Marchbanks, P. Negri, E. Ness, R. Peeters, P. H. M. Vessey, M. Calle, E. E. Gapstur, S. M. Patel, A. V. Dal Maso, L. Talamini, R. Chetrit, A. and Hirsh-Yechezkel, G. Lubin, F. Sadetzki, S. Banks, E. and Bull, D. Callaghan, K. Crossley, B. Goodill, A. Green, J. Key, T. Sitas, F. Collins, R. Doll, R. Gonzalez, A. Lee, N. Ory, H. W. Peterson, H. B. Wingo, P. A. and Martin, N. Pardthaisong, T. Silpisornkosol, S. Theetranont, C. Boosiri, B. Chutivongse, S. Jimakorn, P. Virutamasen, P. Wongsrichanalai, C. Tjonneland, A. Titus-Ernstoff, L. and Byers, T. Rohan, T. Mosgaard, B. J. Yeates, D. and Freudenheim, J. L. Chang-Claude, J. Kaaks, R. Anderson, K. E. Folsom, A. Robien, K. Hampton, J. Newcomb, P. A. and Rossing, M. A. Thomas, D. B. Weiss, N. S. Riboli, E. and Clavel-Chapelon, F. Cramer, D. Hankinson, S. E. Tworoger, S. S. Franceschi, S. La Vecchia, C. Adami, H. O. Magnusson, C. Riman, T. Weiderpass, E. Wolk, A. Schouten, L. J. and van den Brandt, P. A. Chantarakul, N. Koetsawang, S. and Rachawat, D. Palli, D. Black, A. Freedman, D. M. Hartge, P. Hsing, A. W. Lacey, Jr., J. V. Hoover, R. N. and Schairer, C. Urban, M. Graff-Iversen, S. Selmer, R. and Bain, C. J. Green, A. C. Purdie, D. M. Siskind, V. Webb, P. M. Moysich, K. McCann, S. E. Hannaford, P. Kay, C. and Binns, C. W. Lee, A. H. Zhang, M. Nasca, P. Coogan, P. F. Palmer, J. R. Rosenberg, L. Kelsey, J. and Paffenbarger, R. Whittemore, A. Katsouyanni, K. and Trichopoulou, A. Trichopoulos, D. Tzonou, A. Dabancens, A. and Martinez, L. Molina, R. Salas, O. Goodman, M. T. and Lurie, G. Carney, M. E. Wilkens, L. R. Hartman, L. and Manjer, J. Olsson, H. Grisso, J. A. Morgan, M. Wheeler, J. E. Bunker, C. H. Edwards, R. P. Modugno, F. and Casagrande, J. Pike, M. C. Ross, R. K. Wu, A. H. Miller, A. B. Kumle, M. Gram, I. T. Lund, E. McGowan, L. and Shu, X. O. Zheng, W. Farley, T. M. M. Holck, S. Meirik, O. Risch, H. A. Collaborative Grp Epidemiological Natl Israeli Study Ovarian Canc Nurses Hlth Study
- Abstract
Background Smoking has been linked to mucinous ovarian cancer, but its effects on other ovarian cancer subtypes and on overall ovarian cancer risk are unclear, and the findings from most studies with relevant data are unpublished. To assess these associations, we review the published and unpublished evidence. Methods Eligible epidemiological studies were identified by electronic searches, review articles, and discussions with colleagues. Individual participant data for 28 114 women with and 94 942 without ovarian cancer from 51 epidemiological studies were analysed centrally, yielding adjusted relative risks (RRs) of ovarian cancer in smokers compared with never smokers. Findings After exclusion of studies with hospital controls, in which smoking could have affected recruitment, overall ovarian cancer incidence was only slightly increased in current smokers compared with women who had never smoked (RR 1.06, 95% CI 1.01-1.11, p=0.01). Of 17 641 epithelial cancers with specified histology, 2314 (13%) were mucinous, 2360 (13%) endometrioid, 969 (5%) clear-cell, and 9086 (52%) serous. Smoking-related risks varied substantially across these subtypes (p(heterogeneity)
- Published
- 2012
12. Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies
- Author
-
Beral, V. Hermon, C. Peto, R. Reeves, G. Brinton, L. and Marchbanks, P. Negri, E. Ness, R. Peeters, P. H. M. and Vessey, M. Calle, E. E. Gapstur, S. M. Patel, A. V. Dal Maso, L. Talamini, R. Chetrit, A. Hirsh-Yechezkel, G. and Lubin, F. Sadetzki, S. Allen, N. Bull, D. Callaghan, K. and Crossley, B. Gaitskell, K. Goodill, A. Green, J. and Key, T. Moser, K. Collins, R. Doll, R. Gonzalez, C. A. and Lee, N. Ory, H. W. Peterson, H. B. Wingo, P. A. and Martin, N. Pardthaisong, T. Silpisornkosol, S. Theetranont, C. Boosiri, B. Chutivongse, S. Jimakorn, P. Virutamasen, P. Wongsrichanalai, C. Tjonneland, A. Titus-Ernstoff, L. and Byers, T. Rohan, T. Mosgaard, B. J. Yeates, D. and Freudenheim, J. L. Chang-Claude, J. Kaaks, R. Anderson, K. E. Folsom, A. Robien, K. Rossing, M. A. Thomas, D. B. and Weiss, N. S. Riboli, E. Clavel-Chapelon, F. Cramer, D. and Hankinson, S. E. Tworoger, S. S. Franceschi, S. La Vecchia, C. Magnusson, C. Riman, T. Weiderpass, E. Wolk, A. Schouten, L. J. van den Brandt, P. A. Chantarakul, N. and Koetsawang, S. Rachawat, D. Palli, D. Black, A. de Gonzalez, A. Berrington Freedman, D. M. Hartge, P. Hsing, A. W. Lacey, Jr., J. V. Hoover, R. N. Schairer, C. and Graff-Iversen, S. Selmer, R. Bain, C. J. Green, A. C. and Purdie, D. M. Siskind, V. Webb, P. M. McCann, S. E. and Hannaford, P. Kay, C. Binns, C. W. Lee, A. H. Zhang, M. and Ness, R. B. Nasca, P. Coogan, P. F. Palmer, J. R. and Rosenberg, L. Kelsey, J. Paffenbarger, R. Whittemore, A. and Katsouyanni, K. Trichopoulou, A. Trichopoulos, D. Tzonou, A. and Dabancens, A. Martinez, L. Molina, R. Salas, O. and Goodman, M. T. Lurie, G. Carney, M. E. Wilkens, L. R. and Hartman, L. Manjer, J. Olsson, H. Grisso, J. A. Morgan, M. Wheeler, J. E. Casagrande, J. Pike, M. C. Ross, R. K. and Wu, A. H. Miller, A. B. Kumle, M. Lund, E. McGowan, L. Shu, X. O. Zheng, W. Farley, T. M. M. Holck, S. and Meirik, O. Risch, H. A. Collaborative Grp Epidemiol Studie
- Abstract
Background: Only about half the studies that have collected information on the relevance of women’s height and body mass index to their risk of developing ovarian cancer have published their results, and findings are inconsistent. Here, we bring together the worldwide evidence, published and unpublished, and describe these relationships. Methods and Findings: Individual data on 25,157 women with ovarian cancer and 81,311 women without ovarian cancer from 47 epidemiological studies were collected, checked, and analysed centrally. Adjusted relative risks of ovarian cancer were calculated, by height and by body mass index. Ovarian cancer risk increased significantly with height and with body mass index, except in studies using hospital controls. For other study designs, the relative risk of ovarian cancer per 5 cm increase in height was 1.07 (95% confidence interval [CI], 1.05-1.09; p
- Published
- 2012
13. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls
- Author
-
Beral, V. Doll, R. Hermon, C. Peto, R. Reeves, G. and Brinton, L. Green, A. C. Marchbanks, P. Negri, E. Ness, R. Peeters, P. Vessey, M. Calle, E. E. Rodriguez, C. and Dal Maso, L. Talamini, R. Cramer, D. Hankinson, S. E. and Tworoger, S. S. Chetrit, A. Hirsh-Yechezkel, G. Lubin, F. and Sadetzki, S. Appleby, P. Banks, E. de Gonzalez, A. Berrington Bull, D. Crossley, B. Goodil, A. Green, I. and Green, J. Key, T. Collins, R. Gonzalez, C. A. Lee, N. Ory, H. W. Peterson, H. B. Wingo, P. A. Martin, N. and Pardthaisong, T. Silpisornkosol, S. Theetranont, C. and Boosiri, B. Chutivongse, S. Jimakorn, P. Virutamasen, P. and Wongsrichanalai, C. Titus-Ernstoff, L. Mosgaard, M. J. and Yeates, D. Chang-Claude, J. Rossing, M. A. Thomas, D. and Weiss, N. Franceschi, S. La Vecchia, C. Adami, H. O. and Magnusson, C. Riman, T. Weiderpass, E. Wolk, A. Brinton, L. A. Freedman, D. M. Hartge, P. Lacey, J. M. Hoover, R. and Schouten, L. J. van den Brandt, P. A. Chantarakul, N. and Koetsawang, S. Rachawat, D. Graff-Iversen, S. Selmer, R. and Bain, C. J. Green, A. C. Purdie, D. M. Siskind, V. Webb, P. M. McCann, S. E. Hannaford, P. Kay, C. Binns, C. W. and Lee, A. H. Zhang, M. Nasca, P. Coogan, P. F. Kelsey, J. Paffenbarger, R. Whittemore, A. Katsouyanni, K. and Trichopoulou, A. Trichopoulos, D. Tzonou, A. Dabancens, A. and Martinez, L. Molina, R. Salas, O. Goodman, M. T. and Laurie, G. Carney, M. E. Wilkens, L. R. Bladstrom, A. and Olsson, H. Ness, R. B. Grisso, J. A. Morgan, M. Wheeler, J. E. Peeters, P. Casagrande, J. Pike, M. C. Ross, R. K. and Wu, A. H. Kumle, M. Lund, E. McGowan, L. Shu, X. O. and Zheng, W. Farley, T. M. M. Holck, S. Meirik, O. and Risch, H. A. Collaborative Grp Epidemiological
- Abstract
Background Oral contraceptives were introduced almost 50 years ago, and over 100 million women currently use them. Oral contraceptives can reduce the risk of ovarian cancer, but the eventual public-health effects of this reduction will depend on how long the protection lasts after use ceases. We aimed to assess these effects. Methods Individual data for 23 257 women with ovarian cancer (cases) and 87 303 without ovarian cancer (controls) from 45 epidemiological studies in 21 countries were checked and analysed centrally. The relative risk of ovarian cancer in relation to oral contraceptive use was estimated, stratifying by study, age, parity, and hysterectomy. Findings Overall 7308 (31%) cases and 32 717 (37%) controls had ever used oral contraceptives, for average durations among users of 4 . 4 and 5 . 0 years, respectively. The median year of cancer diagnosis was 1993, when cases were aged an average of 56 years. The longer that women had used oral contraceptives, the greater the reduction in ovarian cancer risk (p
- Published
- 2008
14. Ovarian Cancer and Body Size : Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies
- Author
-
Beral, V., Hermon, C., Peto, R., Reeves, G., Brinton, L., Marchbanks, P., Negri, E., Ness, R., Peeters, P. H. M., Vessey, M., Calle, E. E., Gapstur, S. M., Patel, A. V., Dal Maso, L., Talamini, R., Chetrit, A., Hirsh-Yechezkel, G., Lubin, F., Sadetzki, S., Allen, N., Bull, D., Callaghan, K., Crossley, B., Gaitskell, K., Goodill, A., Green, J., Key, T., Moser, K., Collins, R., Doll, R., Gonzalez, C. A., Lee, N., Ory, H. W., Peterson, H. B., Wingo, P. A., Martin, N., Pardthaisong, T., Silpisornkosol, S., Theetranont, C., Boosiri, B., Chutivongse, S., Jimakorn, P., Virutamasen, P., Wongsrichanalai, C., Tjonneland, A., Titus-Ernstoff, L., Byers, T., Rohan, T., Mosgaard, B. J., Yeates, D., Freudenheim, J. L., Chang-Claude, J., Kaaks, R., Anderson, K. E., Folsom, A., Robien, K., Rossing, M. A., Thomas, D. B., Weiss, N. S., Riboli, E., Clavel-Chapelon, F., Cramer, D., Hankinson, S. E., Tworoger, S. S., Franceschi, S., La Vecchia, C., Magnusson, C., Riman, T., Weiderpass, E., Wolk, A., Schouten, L. J., van den Brandt, P. A., Chantarakul, N., Koetsawang, S., Rachawat, D., Palli, D., Black, A., de Gonzalez, A. Berrington, Freedman, D. M., Hartge, P., Hsing, A. W., Lacey, J. V., Jr., Hoover, R. N., Schairer, C., Graff-Iversen, S., Selmer, R., Bain, C. J., Green, A. C., Purdie, D. M., Siskind, V., Webb, P. M., McCann, S. E., Hannaford, P., Kay, C., Binns, C. W., Lee, A. H., Zhang, M., Ness, R. B., Nasca, P., Coogan, P. F., Palmer, J. R., Rosenberg, L., Kelsey, J., Paffenbarger, R., Whittemore, A., Katsouyanni, K., Trichopoulou, A., Trichopoulos, D., Tzonou, A., Dabancens, A., Martinez, L., Molina, R., Salas, O., Goodman, M. T., Lurie, G., Carney, M. E., Wilkens, L. R., Hartman, L., Manjer, J., Olsson, H., Grisso, J. A., Morgan, M., Wheeler, J. E., Casagrande, J., Pike, M. C., Ross, R. K., Wu, A. H., Miller, A. B., Kumle, M., Lund, E., McGowan, L., Shu, X. O., Zheng, W., Farley, T. M. M., Holck, S., Meirik, O., Risch, H. A., Beral, V., Hermon, C., Peto, R., Reeves, G., Brinton, L., Marchbanks, P., Negri, E., Ness, R., Peeters, P. H. M., Vessey, M., Calle, E. E., Gapstur, S. M., Patel, A. V., Dal Maso, L., Talamini, R., Chetrit, A., Hirsh-Yechezkel, G., Lubin, F., Sadetzki, S., Allen, N., Bull, D., Callaghan, K., Crossley, B., Gaitskell, K., Goodill, A., Green, J., Key, T., Moser, K., Collins, R., Doll, R., Gonzalez, C. A., Lee, N., Ory, H. W., Peterson, H. B., Wingo, P. A., Martin, N., Pardthaisong, T., Silpisornkosol, S., Theetranont, C., Boosiri, B., Chutivongse, S., Jimakorn, P., Virutamasen, P., Wongsrichanalai, C., Tjonneland, A., Titus-Ernstoff, L., Byers, T., Rohan, T., Mosgaard, B. J., Yeates, D., Freudenheim, J. L., Chang-Claude, J., Kaaks, R., Anderson, K. E., Folsom, A., Robien, K., Rossing, M. A., Thomas, D. B., Weiss, N. S., Riboli, E., Clavel-Chapelon, F., Cramer, D., Hankinson, S. E., Tworoger, S. S., Franceschi, S., La Vecchia, C., Magnusson, C., Riman, T., Weiderpass, E., Wolk, A., Schouten, L. J., van den Brandt, P. A., Chantarakul, N., Koetsawang, S., Rachawat, D., Palli, D., Black, A., de Gonzalez, A. Berrington, Freedman, D. M., Hartge, P., Hsing, A. W., Lacey, J. V., Jr., Hoover, R. N., Schairer, C., Graff-Iversen, S., Selmer, R., Bain, C. J., Green, A. C., Purdie, D. M., Siskind, V., Webb, P. M., McCann, S. E., Hannaford, P., Kay, C., Binns, C. W., Lee, A. H., Zhang, M., Ness, R. B., Nasca, P., Coogan, P. F., Palmer, J. R., Rosenberg, L., Kelsey, J., Paffenbarger, R., Whittemore, A., Katsouyanni, K., Trichopoulou, A., Trichopoulos, D., Tzonou, A., Dabancens, A., Martinez, L., Molina, R., Salas, O., Goodman, M. T., Lurie, G., Carney, M. E., Wilkens, L. R., Hartman, L., Manjer, J., Olsson, H., Grisso, J. A., Morgan, M., Wheeler, J. E., Casagrande, J., Pike, M. C., Ross, R. K., Wu, A. H., Miller, A. B., Kumle, M., Lund, E., McGowan, L., Shu, X. O., Zheng, W., Farley, T. M. M., Holck, S., Meirik, O., and Risch, H. A.
- Abstract
Background: Only about half the studies that have collected information on the relevance of women's height and body mass index to their risk of developing ovarian cancer have published their results, and findings are inconsistent. Here, we bring together the worldwide evidence, published and unpublished, and describe these relationships. Methods and Findings: Individual data on 25,157 women with ovarian cancer and 81,311 women without ovarian cancer from 47 epidemiological studies were collected, checked, and analysed centrally. Adjusted relative risks of ovarian cancer were calculated, by height and by body mass index. Ovarian cancer risk increased significantly with height and with body mass index, except in studies using hospital controls. For other study designs, the relative risk of ovarian cancer per 5 cm increase in height was 1.07 (95% confidence interval [CI], 1.05-1.09; p<0.001); this relationship did not vary significantly by women's age, year of birth, education, age at menarche, parity, menopausal status, smoking, alcohol consumption, having had a hysterectomy, having first degree relatives with ovarian or breast cancer, use of oral contraceptives, or use of menopausal hormone therapy. For body mass index, there was significant heterogeneity (p<0.001) in the findings between ever-users and never-users of menopausal hormone therapy, but not by the 11 other factors listed above. The relative risk for ovarian cancer per 5 kg/m(2) increase in body mass index was 1.10 (95% CI, 1.07-1.13; p<0.001) in never-users and 0.95 (95% CI, 0.92-0.99; p = 0.02) in ever-users of hormone therapy. Conclusions: Ovarian cancer is associated with height and, among never-users of hormone therapy, with body mass index. In high-income countries, both height and body mass index have been increasing in birth cohorts now developing the disease. If all other relevant factors had remained constant, then these increases in height and weight would be associated with
- Published
- 2012
- Full Text
- View/download PDF
15. Prospective Study of Ultraviolet Radiation Exposure and Mortality Risk in the United States
- Author
-
Lin, S.-W., primary, Wheeler, D. C., additional, Park, Y., additional, Spriggs, M., additional, Hollenbeck, A. R., additional, Freedman, D. M., additional, and Abnet, C. C., additional
- Published
- 2013
- Full Text
- View/download PDF
16. A Prospective Study of Medical Diagnostic Radiography and Risk of Thyroid Cancer
- Author
-
Neta, G., primary, Rajaraman, P., additional, Berrington de Gonzalez, A., additional, Doody, M. M., additional, Alexander, B. H., additional, Preston, D., additional, Simon, S. L., additional, Melo, D., additional, Miller, J., additional, Freedman, D. M., additional, Linet, M. S., additional, and Sigurdson, A. J., additional
- Published
- 2013
- Full Text
- View/download PDF
17. Circulating 25-Hydroxyvitamin D and Risk of Non-Hodgkin Lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
- Author
-
Purdue, M. P., primary, Freedman, D. M., additional, Gapstur, S. M., additional, Helzlsouer, K. J., additional, Laden, F., additional, Lim, U., additional, Maskarinec, G., additional, Rothman, N., additional, Shu, X.-O., additional, Stevens, V. L., additional, Zeleniuch-Jacquotte, A., additional, Albanes, D., additional, Bertrand, K., additional, Weinstein, S. J., additional, Yu, K., additional, Irish, L., additional, Horst, R. L., additional, Hoffman-Bolton, J., additional, Giovannucci, E. L., additional, Kolonel, L. N., additional, Snyder, K., additional, Willett, W., additional, Arslan, A. A., additional, Hayes, R. B., additional, Zheng, W., additional, Xiang, Y.-B., additional, and Hartge, P., additional
- Published
- 2010
- Full Text
- View/download PDF
18. Correlates of Circulating 25-Hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
- Author
-
McCullough, M. L., primary, Weinstein, S. J., additional, Freedman, D. M., additional, Helzlsouer, K., additional, Flanders, W. D., additional, Koenig, K., additional, Kolonel, L., additional, Laden, F., additional, Le Marchand, L., additional, Purdue, M., additional, Snyder, K., additional, Stevens, V. L., additional, Stolzenberg-Solomon, R., additional, Virtamo, J., additional, Yang, G., additional, Yu, K., additional, Zheng, W., additional, Albanes, D., additional, Ashby, J., additional, Bertrand, K., additional, Cai, H., additional, Chen, Y., additional, Gallicchio, L., additional, Giovannucci, E., additional, Jacobs, E. J., additional, Hankinson, S. E., additional, Hartge, P., additional, Hartmuller, V., additional, Harvey, C., additional, Hayes, R. B., additional, Horst, R. L., additional, and Shu, X.-O., additional
- Published
- 2010
- Full Text
- View/download PDF
19. Circulating 25-Hydroxyvitamin D and the Risk of Rarer Cancers: Design and Methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
- Author
-
Gallicchio, L., primary, Helzlsouer, K. J., additional, Chow, W.-H., additional, Freedman, D. M., additional, Hankinson, S. E., additional, Hartge, P., additional, Hartmuller, V., additional, Harvey, C., additional, Hayes, R. B., additional, Horst, R. L., additional, Koenig, K. L., additional, Kolonel, L. N., additional, Laden, F., additional, McCullough, M. L., additional, Parisi, D., additional, Purdue, M. P., additional, Shu, X.-O., additional, Snyder, K., additional, Stolzenberg-Solomon, R. Z., additional, Tworoger, S. S., additional, Varanasi, A., additional, Virtamo, J., additional, Wilkens, L. R., additional, Xiang, Y.-B., additional, Yu, K., additional, Zeleniuch-Jacquotte, A., additional, Zheng, W., additional, Abnet, C. C., additional, Albanes, D., additional, Bertrand, K., additional, and Weinstein, S. J., additional
- Published
- 2010
- Full Text
- View/download PDF
20. Nonradiation Risk Factors for Thyroid Cancer in the US Radiologic Technologists Study
- Author
-
Meinhold, C. L., primary, Ron, E., additional, Schonfeld, S. J., additional, Alexander, B. H., additional, Freedman, D. M., additional, Linet, M. S., additional, and Berrington de Gonzalez, A., additional
- Published
- 2009
- Full Text
- View/download PDF
21. Risk of Cataract after Exposure to Low Doses of Ionizing Radiation: A 20-Year Prospective Cohort Study among US Radiologic Technologists
- Author
-
Chodick, G., primary, Bekiroglu, N., additional, Hauptmann, M., additional, Alexander, B. H., additional, Freedman, D. M., additional, Doody, M. M., additional, Cheung, L. C., additional, Simon, S. L., additional, Weinstock, R. M., additional, Bouville, A., additional, and Sigurdson, A. J., additional
- Published
- 2008
- Full Text
- View/download PDF
22. Prospective Study of Serum Vitamin D and Cancer Mortality in the United States
- Author
-
Freedman, D. M., primary, Looker, A. C., additional, Chang, S.-C., additional, and Graubard, B. I., additional
- Published
- 2007
- Full Text
- View/download PDF
23. RE: "FROM MENARCHE TO MENOPAUSE: TRENDS AMONG US WOMEN BORN FROM 1912 TO 1969"
- Author
-
Freedman, D. M., primary and Tarone, R. E., additional
- Published
- 2007
- Full Text
- View/download PDF
24. Smoking Cigarettes before First Childbirth and Risk of Breast Cancer
- Author
-
Ha, M., primary, Mabuchi, K., additional, Sigurdson, A. J., additional, Freedman, D. M., additional, Linet, M. S., additional, Doody, M. M., additional, and Hauptmann, M., additional
- Published
- 2007
- Full Text
- View/download PDF
25. Assessing Activities Associated with Time Spent Outdoors in an Occupational Cohort of Radiologic Technologists
- Author
-
Kwok, R K, primary, Fears, T, additional, Kleinerman, R A, additional, Freedman, D M, additional, Alexander, B H, additional, Kampa, D, additional, Johnson, R E, additional, and Linet, M S, additional
- Published
- 2006
- Full Text
- View/download PDF
26. Lung Cancer Incidence Among U.S. Radiologic Technologists, 1983–1998
- Author
-
Rajaraman, P, primary, Sigurdson, A J, additional, Doody, M M, additional, Freedman, D M, additional, Hauptmann, M, additional, Ron, E, additional, Alexander, B H, additional, and Linet, M S, additional
- Published
- 2006
- Full Text
- View/download PDF
27. Risk of Malignant Mixed Mullerian Tumors After Tamoxifen Therapy for Breast Cancer
- Author
-
Curtis, R. E., primary, Freedman, D. M., additional, Sherman, M. E., additional, and Fraumeni, J. F., additional
- Published
- 2004
- Full Text
- View/download PDF
28. Compartment Reconstruction for De Quervain’s Disease
- Author
-
LITTLER, J. W., primary, FREEDMAN, D. M., additional, and MALERICH, M. M., additional
- Published
- 2002
- Full Text
- View/download PDF
29. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates
- Author
-
Freedman, D M., primary
- Published
- 2000
- Full Text
- View/download PDF
30. Nitrates in Drinking Water and Non-Hodgkinʼs Lymphoma
- Author
-
Freedman, D M, primary, Cantor, K P, additional, Ward, M H, additional, and Helzlsouer, K J, additional
- Published
- 1998
- Full Text
- View/download PDF
31. COMPARISON OF CANCER RISK ESTIMATES USING RECENT AND LIFETIME MEASURES OF EXPOSURE TO DRINKING WATER CONTAMINANTS
- Author
-
Cantor, K P, primary, Hildesheim, M E, additional, Freedman, D M, additional, and Lynch, C F, additional
- Published
- 1998
- Full Text
- View/download PDF
32. The Influence of Joint Laxity on Periscaphoid Carpal Kinematics
- Author
-
FREEDMAN, D. M., primary and GARCIA-ELIAS, M., additional
- Published
- 1997
- Full Text
- View/download PDF
33. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study
- Author
-
Freedman, D M., primary, Zahm, S. H., additional, and Dosemeci, M., additional
- Published
- 1997
- Full Text
- View/download PDF
34. A comparison of recent and long-term average measurements of nitrate in drinking water.
- Author
-
FREEDMAN, D M I C H A L, CANTOR, KENNETH P, WARD, MARY H, and HELZLSOUER, KATHY J
- Subjects
- *
DRINKING water , *NITRATES & the environment , *EPIDEMIOLOGY - Abstract
We evaluated the usefulness of a recent measure of drinking water nitrate as a predictor of long-term average nitrate exposure calculated from historic data. Exposure estimates were calculated for 214 study participants who used public water supplies between 1947 and 1980 in Minnesota. Long-term average nitrate was calculated by linking residential histories to historical nitrate data. For recent exposures, we averaged nitrate measurements in 1980, or the next closest year with measurements. The Spearman correlation coefficient for the relationship between the two measures was 0.54 (95% confidence interval [CI] = 0.44-0.63). Agreement was highest among those residing 34 or more years in their town as of 1980 (r[SUBs] = 0.70; 95% CI = 0.55-0.80). These findings suggest that taking into account the study participants' duration of residence may enhance the validity of using a recent measure as an indicator of past exposures. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
35. Ipsilateral hip and knee dislocation.
- Author
-
Freedman, Douglas M., Freedman, Eric L., Shapiro, Matthew S., Freedman, D M, Freedman, E L, and Shapiro, M S
- Published
- 1994
- Full Text
- View/download PDF
36. Genetic analysis of in vivo-selected viral variants causing chronic infection: importance of mutation in the L RNA segment of lymphocytic choriomeningitis virus
- Author
-
Ahmed, R, Simon, R S, Matloubian, M, Kolhekar, S R, Southern, P J, and Freedman, D M
- Abstract
Viral variants with different biological properties are present in the central nervous systems (CNS) and lymphoid tissues of mice persistently infected with lymphocytic choriomeningitis virus (LCMV). Viral isolates from the CNS are similar to the original Armstrong LCMV strain and induce potent virus-specific T-cell responses in adult mice, and the infection is rapidly cleared. In contrast, LCMV isolates derived from spleens of carrier mice cause persistent infections in adult mice. This chronic infection is associated with low levels of antiviral T-cell responses. In this study, we genetically characterized two independently derived spleen variants by making recombinants (reassortants) between the spleen isolates and wild-type (wt) LCMV and showed that the ability to persist in adult mice and the associated suppression of T-cell responses segregates with the large (L) RNA segment. In addition, we analyzed a revertant (isolated from the CNS) derived from one of the spleen variants. By comparing the biological properties of three reassortants that contained the same S segment but had the L segment of either the original wt Armstrong LCMV, the spleen variant derived from it, or the CNS revertant derived from the spleen variant, we were able to show unequivocally that biologically relevant mutations occurred in the L segment not only during generation of the spleen variant from wt LCMV but also in reversion of the spleen variant to the wt phenotype. Thus, our results showed that (i) genetic alterations in the L genomic segment were involved in organ-specific selection of viral variants, and (ii) these mutations profoundly affected the ability of LCMV to cause chronic infections in adult mice.
- Published
- 1988
- Full Text
- View/download PDF
37. Letters to the Editor.
- Author
-
Roberts, Lois, Overton, George W., and Freedman, D. M.
- Subjects
LETTERS to the editor ,DISPUTE resolution ,ARBITRATION & award ,CONFLICT management - Abstract
Presents several letters to the editor in reference to articles and topics discussed in previous issues. "The Attorney and the Non-Attorney Arbitrator," which discusses the engineer-arbitrator's style, published in the Fall 1997 issue; Remarks on the policy statement of the U.S. Equal Employment Opportunity Commission regarding mandatory mediation.
- Published
- 1998
38. Nitrates in Drinking Water and NonHodgkin's Lymphoma
- Author
-
Freedman, D M, Cantor, K P, Ward, M H, and Helzlsouer, K J
- Published
- 1998
39. Coffee, tea, and caffeine intake and amyotrophic lateral sclerosis mortality in a pooled analysis of eight prospective cohort studies.
- Author
-
Petimar J, O'Reilly É, Adami HO, van den Brandt PA, Buring J, English DR, Freedman DM, Giles GG, Håkansson N, Kurth T, Larsson SC, Robien K, Schouten LJ, Weiderpass E, Wolk A, and Smith-Warner SA
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prospective Studies, Amyotrophic Lateral Sclerosis mortality, Caffeine, Coffee, Risk Assessment, Tea
- Abstract
Background and Purpose: Caffeine is associated with a lower risk of some neurological diseases, but few prospective studies have investigated caffeine intake and risk of amyotrophic lateral sclerosis (ALS) mortality. We therefore determined associations between coffee, tea and caffeine intake, and risk of ALS mortality., Methods: We conducted pooled analyses of eight international, prospective cohort studies, including 351 565 individuals (120 688 men and 230 877 women). We assessed coffee, tea and caffeine intake using validated food-frequency questionnaires administered at baseline. We used Cox regression to estimate study- and sex-specific risk ratios and 95% confidence intervals (CI) for ALS mortality, which were then pooled using a random-effects model. We conducted analyses using cohort-specific tertiles, absolute common cut-points and continuous measures of all exposures., Results: During follow-up, 545 ALS deaths were documented. We did not observe statistically significant associations between coffee, tea or caffeine intake and risk of ALS mortality. The pooled multivariable risk ratio (MVRR) for ≥3 cups per day vs. >0 to <1 cup per day was 1.04 (95% CI, 0.74-1.47) for coffee and 1.17 (95% CI, 0.77-1.79) for tea. The pooled MVRR comparing the highest with the lowest tertile of caffeine intake (mg/day) was 0.99 (95% CI, 0.80-1.23). No statistically significant results were observed when exposures were modeled as tertiles or continuously., Conclusions: Our results do not support associations between coffee, tea or total caffeine intake and risk of ALS mortality., (© 2018 EAN.)
- Published
- 2019
- Full Text
- View/download PDF
40. Mortality due to amyotrophic lateral sclerosis and Parkinson's disease among melanoma patients.
- Author
-
Baade PD, Fritschi L, and Freedman DM
- Subjects
- Amyotrophic Lateral Sclerosis complications, Australia epidemiology, Cohort Studies, Female, Humans, Male, Melanoma mortality, Melanoma pathology, Parkinson Disease complications, Risk Assessment, Skin Neoplasms mortality, Skin Neoplasms pathology, Time Factors, Amyotrophic Lateral Sclerosis mortality, Melanoma complications, Parkinson Disease mortality, Skin Neoplasms complications
- Abstract
Recent studies in the USA and elsewhere have identified a possible association between Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and melanoma. However, empirical evidence is very limited. We conducted a study of all people diagnosed as having melanoma in Australia since 1982 (n = 127,037). The subjects, excluding those who had died within 12 months of diagnosis, were followed until 31 December 2001. We then compared their mortality risk of ALS and PD to that of the general population. There were a total of 53 ALS deaths and 129 deaths due to PD. Although the absolute risk is small, the melanoma cohort had a risk of death due to ALS 70% higher (standardised mortality ratio = 169.4, 95% CI = 127-221) than the general population, and nearly a 3-fold increased risk of dying from PD (standardised mortality ratio = 266.3, 95% CI = 222-317). These increased risks continued for long-term survivors, arguing against a surveillance effect (particularly for ALS). The consistency of these results in 2 separate populations (Australia and USA) strengthens the evidence for an association between melanoma and each of the 2 neurodegenerative diseases.
- Published
- 2007
- Full Text
- View/download PDF
41. Household solvent exposures and childhood acute lymphoblastic leukemia.
- Author
-
Freedman DM, Stewart P, Kleinerman RA, Wacholder S, Hatch EE, Tarone RE, Robison LL, and Linet MS
- Subjects
- Child, Child, Preschool, Data Collection, Female, Humans, Infant, Male, Precursor Cell Lymphoblastic Leukemia-Lymphoma epidemiology, Risk Assessment, United States epidemiology, Environmental Exposure, Household Products adverse effects, Precursor Cell Lymphoblastic Leukemia-Lymphoma chemically induced, Solvents adverse effects
- Abstract
Objectives: This study explored the risk of childhood acute lymphoblastic leukemia (ALL) associated with participation by household members in hobbies or other home projects involving organic solvents., Methods: Participants in this case-control study were 640 subjects with ALL and 640 matched controls., Results: Childhood ALL was associated with frequent (> 4 times/month) exposure to model building (odds ratio [OR] = 1.9; 95% confidence interval [95% CI] = 0.7, 5.8) and artwork using solvents (OR = 4.1; 95% CI = 1.1, 15.1). We also found elevated risk (OR = 1.7; 95% CI = 1.1, 2.7) among children whose mothers lived in homes painted extensively (> 4 rooms) in the year before the children's birth., Conclusions: In this exploratory study, substantial participation by household members in some common household activities that involve organic solvents was associated with elevated risks of childhood ALL.
- Published
- 2001
- Full Text
- View/download PDF
42. Vascularity of the carpus.
- Author
-
Freedman DM, Botte MJ, and Gelberman RH
- Subjects
- Hand blood supply, Humans, Lunate Bone blood supply, Osteonecrosis diagnosis, Osteonecrosis pathology, Radial Artery anatomy & histology, Scaphoid Bone blood supply, Ulnar Artery anatomy & histology, Carpal Bones blood supply
- Abstract
Relatively few studies investigating the vascular patterns of the carpus have been performed. Technical difficulties in identifying small vessels in three dimensions and in determining their location within the thick ligaments about the wrist have led to conflicting anatomic reports. Studies on cadavers in which improved techniques with arterial injection, chemical debridement, and decalcification were used allowed the arterial anatomy of the carpus to be delineated more accurately. The current authors review these arterial patterns, with attention given to the extraosseous and intraosseous vascularities.
- Published
- 2001
- Full Text
- View/download PDF
43. A case-control study of nitrate in drinking water and non-Hodgkin's lymphoma in Minnesota.
- Author
-
Freedman DM, Cantor KP, Ward MH, and Helzlsouer KJ
- Subjects
- Adult, Age Distribution, Aged, Case-Control Studies, Confidence Intervals, Drinking, Female, Humans, Incidence, Logistic Models, Lymphoma, Non-Hodgkin etiology, Male, Middle Aged, Minnesota epidemiology, Odds Ratio, Population Surveillance, Reference Values, Risk Factors, Sex Distribution, Lymphoma, Non-Hodgkin epidemiology, Nitrates adverse effects, Water Pollution, Chemical adverse effects, Water Supply analysis
- Abstract
Nitrate in drinking water has been implicated as a possible risk factor for non-Hodgkin's lymphoma. The authors examined the association between non-Hodgkin's lymphoma and waterborne nitrate through a population-based case-control study of white men in Minnesota. The authors, by linking residential histories with community water records, estimated average long-term exposure to nitrate in drinking water from 1947 to 1975 for 73 cases diagnosed between 1980 and 1982 and for 147 controls who used community water supplies. No association was found between nitrate levels in community water supplies and non-Hodgkin's lymphoma within the range of study exposures (median of highest exposure category = 2.4 mg nitrate/l [range = 0.1-7.2 mg/l]). The findings provide some safety assurance for those who use water systems that have nitrate levels that are less than 2.4 mg/l.
- Published
- 2000
- Full Text
- View/download PDF
44. Long-term results of volar ligament reconstruction for symptomatic basal joint laxity.
- Author
-
Freedman DM, Eaton RG, and Glickel SZ
- Subjects
- Adolescent, Adult, Evaluation Studies as Topic, Female, Follow-Up Studies, Humans, Joint Instability diagnostic imaging, Ligaments, Articular diagnostic imaging, Linear Models, Logistic Models, Male, Metacarpophalangeal Joint diagnostic imaging, Middle Aged, Patient Satisfaction, Radiography, Range of Motion, Articular physiology, Plastic Surgery Procedures methods, Thumb diagnostic imaging, Time Factors, Joint Instability surgery, Ligaments, Articular surgery, Metacarpophalangeal Joint physiopathology, Thumb surgery
- Abstract
It has been hypothesized that instability of the thumb trapeziometacarpal joint is a major factor in the etiology of degenerative disease. Theoretically, surgically stabilized joints should be subject to less shear force and, hence, will be less likely to develop degenerative changes. The long-term results of volar ligament reconstruction were assessed in 19 patients (24 thumbs). The average age at surgery was 33 years (range, 18-55 years). Twenty-three thumbs were radiographic stage I; a preoperative x-ray was not available in 1. The follow-up period averaged 15 years (range, 10-23 years). At the final follow-up visit 15 thumbs were stage I, 7 were stage II, and 2 were stage III. Fifteen patients were at least 90% satisfied with the results of the surgery. Only 8% of thumbs advanced to radiographic arthritic disease, which compares favorably with the 17% to 33% reported incidence of stage III/IV basal joint arthritis in the general population., (Copyright 2000 by the American Society for Surgery of the Hand.)
- Published
- 2000
- Full Text
- View/download PDF
45. The effect of beta-carotene supplementation on serum vitamin D metabolite concentrations.
- Author
-
Freedman DM, Tangrea JA, Virtamo J, and Albanes D
- Subjects
- Age Factors, Drug Interactions, Follow-Up Studies, Humans, Incidence, Lung Neoplasms chemically induced, Lung Neoplasms epidemiology, Matched-Pair Analysis, Placebos, Seasons, Statistics, Nonparametric, Time Factors, Vitamin D blood, Antioxidants adverse effects, Vitamin D analogs & derivatives, beta Carotene adverse effects
- Abstract
In the alpha-Tocopherol, beta-Carotene Cancer Prevention (ATBC) study, a large randomized placebo-controlled trial designed to test the cancer prevention effects of alpha-tocopherol (50 mg/day) and beta-carotene (20 mg/day), participants receiving supplemental beta-carotene had significantly higher rates of lung cancer than those not receiving beta-carotene. It has been hypothesized that the supplemental beta-carotene may have interfered with the synthesis of vitamin D and that the resulting lower concentrations of vitamin D contributed to the elevated cancer incidence. We evaluated whether supplementation with beta-carotene altered the serum concentrations of either 25-hydroxyvitamin D or 1,25-dihydroxyvitamin D in the ATBC Study, by comparing on-study changes between baseline and follow-up serum samples among 20 randomly selected matched pairs of subjects from the beta-carotene and placebo groups. In a matched-pair analysis, the difference between the changes in both 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the beta-carotene supplement and placebo groups were small and statistically nonsignificant. These results provide no evidence that beta-carotene supplementation interferes with the endogenous production of 25-hydroxyvitamin D or 1,25-dihydroxyvitamin D and suggest that it is unlikely that an interaction between supplemental beta-carotene and vitamin D metabolites contributed to the modest increase in lung cancer incidence observed in the ATBC Study.
- Published
- 1999
46. Maryland's high cancer mortality rate: a review of contributing demographic factors.
- Author
-
Freedman DM
- Subjects
- Adolescent, Adult, Age Distribution, Aged, Child, Child, Preschool, Female, Health Surveys, Humans, Incidence, Male, Maryland epidemiology, Middle Aged, Neoplasms diagnosis, Risk Factors, Sex Distribution, Survival Rate, United States epidemiology, Black or African American statistics & numerical data, Neoplasms mortality, White People statistics & numerical data
- Abstract
For many years, Maryland has ranked among the top states in cancer mortality. This study analyzed mortality data from the National Center for Health Statistics (CDC-Wonder) to help explain Maryland's cancer rate and rank. Age-adjusted rates are based on deaths per 100,000 population from 1991 through 1995. Rates and ranks overall, and stratified by age, are calculated for total cancer mortality, as well as for four major sites: lung, breast, prostate, and colorectal. Because states differ in their racial/gender mix, race/gender rates among states are also compared. Although Maryland ranks seventh in overall cancer mortality, its rates and rank by race and gender subpopulation are less high. For those under 75, white men ranked 26th, black men ranked 20th, and black and white women ranked 12th and 10th, respectively. Maryland's overall rank, as with any state, is a function of the rates of its racial and gender subpopulations and the relative size of these groups in the state. Many of the disparities between Maryland's overall high cancer rank and its lower rank by subpopulation also characterize the major cancer sites. Although a stratified presentation of cancer rates and ranks may be more favorable to Maryland, it should not be used to downplay the attention cancer mortality in Maryland deserves.
- Published
- 1999
47. Tomography versus computed tomography for assessing step off in intraarticular distal radial fractures.
- Author
-
Freedman DM, Dowdle J, Glickel SZ, Singson R, and Okezie T
- Subjects
- Analysis of Variance, Bone Wires, Cadaver, Calibration, Cost Control, Cost-Benefit Analysis, Forecasting, Fracture Fixation, Internal instrumentation, Fracture Fixation, Internal methods, Humans, Joint Dislocations pathology, Joint Dislocations surgery, Radiographic Image Enhancement, Radius Fractures pathology, Radius Fractures surgery, Single-Blind Method, Joint Dislocations diagnostic imaging, Radius Fractures diagnostic imaging, Tomography, X-Ray economics, Tomography, X-Ray Computed economics, Wrist Injuries diagnostic imaging
- Abstract
Computed tomography scans have supplanted conventional tomography for many applications and often are considered the imaging study of choice for assessing intraarticular distal radial fractures. Concern about cost containment in healthcare delivery prompts the question of whether the two studies provide comparable information and at what cost. Common intraarticular distal radial fractures were created in 12 lightly embalmed cadaveric specimens. The fractures were fixed with radiolucent Kirschner wires. Articular step off was measured with a caliper. Plain radiographs, computed tomography scans, and trispiral tomograms were obtained of each specimen. Maximal step off was measured blindly by two musculoskeletal radiologists and four hand surgeons. The radiographic measurements were compared with the actual step off and expressed as a positive or negative deviation from the actual value. There was no statistically significant difference between computed tomography scans and tomograms in predicting step off. In addition, the difference between actual and radiographic measurements was insignificant in tomogram readings and different in one of the computed tomography measurements. In the authors' institution, a tomogram costs $200, and a computed tomography scan costs $562. Trispiral tomography is more accurate and cost effective than computed tomography, and thus when available should be considered the imaging modality of choice for assessing articular step off in distal radius fractures.
- Published
- 1999
- Full Text
- View/download PDF
48. Iatrogenic posterior tibial nerve division during ankle arthroscopy.
- Author
-
Freedman DM and Barron OA
- Subjects
- Ankle Injuries complications, Ankle Injuries therapy, Arthroscopy, Female, Humans, Joint Loose Bodies etiology, Middle Aged, Endoscopy, Iatrogenic Disease, Intraoperative Complications, Joint Loose Bodies surgery, Tibial Nerve surgery
- Abstract
Ankle arthroscopy has been increasingly applied to the diagnostic and therapeutic treatment of ankle disorders. Owing to the complex cutaneous anatomy of the ankle, neurological injuries are a potential complication of this procedure. All reports of neurological complications resulting from ankle arthroscopy have attributed them to use of a distractor pin or to portal placement. Several authors have noted the possibility of damage to the deep peroneal nerve from the use of motorized arthroscopic tools within the anterior ankle joint capsule. We present what we believe to be the first reported case of complete division of the posterior tibial nerve resulting from an apparently overaggressive intra-articular manipulation during ankle arthroscopy performed for loose body removal.
- Published
- 1998
- Full Text
- View/download PDF
49. Right versus left symmetry of ulnar variance. A radiographic assessment.
- Author
-
Freedman DM, Edwards GS Jr, Willems MJ, and Meals RA
- Subjects
- Adult, Age Factors, Analysis of Variance, Asian People, Black People, Confidence Intervals, Female, Functional Laterality, Humans, Linear Models, Male, Middle Aged, Observer Variation, Radiography, Radius anatomy & histology, Radius diagnostic imaging, Radius physiology, Sex Factors, Single-Blind Method, Stress, Mechanical, Ulna anatomy & histology, Ulna physiology, White People, Wrist Joint anatomy & histology, Wrist Joint diagnostic imaging, Wrist Joint physiology, Ulna diagnostic imaging
- Abstract
One hundred skeletally mature healthy volunteers underwent standardized bilateral posteroanterior radiographs in unloaded (static) and loaded (dynamic) conditions to determine the symmetry of ulnar variance. The mean age was 32 +/- 9 years (range, 19-61 years), with 58 women and 42 men. Ulnar variance was measured to the closest 0.5 mm using the method of perpendiculars. Three separate measurements were made of each radiograph in a blinded fashion by the same investigator. An intraobserver standard deviation of 0.21 was used to calculate a 95% tolerance interval of 0.7 mm (rounded up to 1 mm) as a measure of significance. The average static ulnar variance was -0.13 +/- 1.5 mm on the left and -0.29 +/- 1.6 mm on the right. The average dynamic ulnar variance was 0.93 +/- 1.5 mm on the left and 0.82 +/- 1.5 mm on the right. When compared individually, there was a greater than or equal to 1 mm side to side difference in 37% of volunteers under static and 38% under dynamic conditions. There were no significant correlations between ulnar variance measurements and patient age, gender, race, or handedness. Use of the normal wrist radiograph as a baseline for static radial length measurements is valid in only 63% of cases.
- Published
- 1998
- Full Text
- View/download PDF
50. Heterotopic ossification following total knee arthroplasty requiring surgical excision.
- Author
-
Freedman EL and Freedman DM
- Subjects
- Humans, Male, Middle Aged, Ossification, Heterotopic diagnostic imaging, Postoperative Complications diagnostic imaging, Radiography, Knee Prosthesis, Ossification, Heterotopic surgery, Postoperative Complications surgery
- Abstract
We present a case of progressive heterotopic ossification (HO) after cementless total knee arthroplasty causing painful stiffness that was treated with surgical excision. The patient had few risk factors associated with HO, including minimal anterior notching and dissection of the distal femoral cortex. The patient did undergo manipulation; however, this occurred after the diagnosis of HO was made. This report documents a rare case of HO following total knee arthroplasty that required surgical excision.
- Published
- 1996
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.